From: Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia
Day 4 | Day 10 | Day 22 | ||||||
---|---|---|---|---|---|---|---|---|
GO biological process complete | fold enrichment | raw P-value | GO biological process complete | fold enrichment | raw P-value | GO biological process complete | fold enrichment | raw P-value |
negative regulation of platelet activation (GO:0010544) | 47,39 | 5,25E-05 | positive regulation of receptor catabolic process (GO:2000646) | 56,36 | 6,21E-05 | desmosome organization (GO:0002934) | 17,34 | 8,23E-06 |
ovulation (GO:0030728) | 44,9 | 6,06E-05 | intracellular cholesterol transport (GO:0032367) | 25,05 | 4,10E-05 | establishment of skin barrier (GO:0061436) | 15,9 | 2,49E-09 |
negative regulation of hemostasis (GO:1900047) | 23,21 | 3,57E-05 | intracellular sterol transport (GO:0032366) | 23,48 | 5,09E-05 | regulation of water loss via skin (GO:0033561) | 14,45 | 5,36E-09 |
negative regulation of blood coagulation (GO:0030195) | 23,21 | 3,57E-05 | cellular response to sterol (GO:0036315) | 22,1 | 6,23E-05 | cornification (GO:0070268) | 9,55 | 4,19E-22 |
negative regulation of coagulation (GO:0050819) | 21,87 | 4,45E-05 | cellular response to low-density lipoprotein particle stimulus (GO:0071404) | 20,88 | 7,55E-05 | intermediate filament cytoskeleton organization (GO:0045104) | 6,15 | 1,71E-05 |
positive regulation of blood vessel diameter (GO:0097755) | 20,68 | 5,47E-05 | nitric oxide mediated signal transduction (GO:0007263) | 19,78 | 9,07E-05 | intermediate filament-based process (GO:0045103) | 6,02 | 2,01E-05 |
alpha-amino acid catabolic process (GO:1901606) | 14,22 | 3,39E-05 | low-density lipoprotein particle clearance (GO:0034383) | 19,57 | 1,20E-05 | multicellular organismal water homeostasis (GO:0050891) | 5,96 | 1,29E-06 |
cellular amino acid catabolic process (GO:0009063) | 11,95 | 7,50E-05 | cholesterol biosynthetic process (GO:0006695) | 17,89 | 4,91E-08 | water homeostasis (GO:0030104) | 5,95 | 5,17E-07 |
positive regulation of vasculature development (GO:1904018) | 11 | 4,31E-06 | secondary alcohol biosynthetic process (GO:1902653) | 17,48 | 5,77E-08 | keratinization (GO:0031424) | 5,14 | 1,29E-15 |
negative regulation of cell activation (GO:0050866) | 9,43 | 5,00E-05 | regulation of cholesterol biosynthetic process (GO:0045540) | 17,48 | 5,77E-08 | peptide cross-linking (GO:0018149) | 4,9 | 9,40E-05 |
regulation of vasculature development (GO:1901342) | 7,29 | 1,61E-05 | regulation of sterol biosynthetic process (GO:0106118) | 17,48 | 5,77E-08 | skin development (GO:0043588) | 4,7 | 1,78E-21 |
regulation of angiogenesis (GO:0045765) | 7,03 | 7,03E-05 | isoprenoid biosynthetic process (GO:0008299) | 16,2 | 2,69E-05 | regulation of epidermis development (GO:0045682) | 4,64 | 1,46E-05 |
regulation of small molecule metabolic process (GO:0062012) | 6,44 | 3,81E-05 | sterol biosynthetic process (GO:0016126) | 15,66 | 1,23E-07 | keratinocyte differentiation (GO:0030216) | 4,64 | 2,76E-15 |
small molecule biosynthetic process (GO:0044283) | 5,78 | 1,13E-06 | plasma lipoprotein particle clearance (GO:0034381) | 14,09 | 8,41E-06 | epidermal cell differentiation (GO:0009913) | 4,37 | 1,05E-15 |
negative regulation of cell proliferation (GO:0008285) | 5,05 | 4,49E-06 | regulation of cholesterol metabolic process (GO:0090181) | 13,42 | 3,56E-07 | regulation of sodium ion transport (GO:0002028) | 4,32 | 2,87E-05 |
regulation of cell migration (GO:0030334) | 4,54 | 5,33E-06 | interferon-gamma-mediated signaling pathway (GO:0060333) | 13,23 | 1,34E-08 | cell-cell junction organization (GO:0045216) | 4,07 | 9,97E-07 |
regulation of cell motility (GO:2000145) | 4,25 | 1,08E-05 | regulation of alcohol biosynthetic process (GO:1902930) | 12,87 | 1,71E-08 | epidermis development (GO:0008544) | 4,02 | 2,52E-17 |
regulation of locomotion (GO:0040012) | 3,91 | 2,57E-05 | regulation of steroid biosynthetic process (GO:0050810) | 12,45 | 4,44E-09 | cellular response to decreased oxygen levels (GO:0036294) | 3,83 | 1,22E-06 |
regulation of cellular component movement (GO:0051270) | 3,89 | 2,72E-05 | regulation of plasma lipoprotein particle levels (GO:0097006) | 11,74 | 1,84E-07 | negative regulation of immune effector process (GO:0002698) | 3,74 | 3,32E-05 |
secretion by cell (GO:0032940) | 3,78 | 3,62E-05 | regulation of steroid metabolic process (GO:0019218) | 11,74 | 6,70E-11 | cellular response to hypoxia (GO:0071456) | 3,66 | 7,17E-06 |
regulation of immune response (GO:0050776) | 3,52 | 7,42E-05 | cholesterol transport (GO:0030301) | 11,74 | 4,39E-06 | cellular response to oxygen levels (GO:0071453) | 3,46 | 4,92E-06 |
regulation of immune system process (GO:0002682) | 3,12 | 2,23E-05 | cholesterol metabolic process (GO:0008203) | 10,9 | 7,51E-10 | cell junction organization (GO:0034330) | 3,44 | 3,69E-07 |
immune system process (GO:0002376) | 2,76 | 7,14E-07 | secondary alcohol metabolic process (GO:1902652) | 10,44 | 1,22E-09 | epithelial cell differentiation (GO:0030855) | 3,16 | 1,17E-16 |
regulation of developmental process (GO:0050793) | 2,53 | 2,87E-05 | sterol transport (GO:0015918) | 9,96 | 1,18E-05 | regulation of autophagy (GO:0010506) | 3,11 | 7,36E-08 |
regulation of response to stimulus (GO:0048583) | 2,02 | 5,62E-05 | cholesterol homeostasis (GO:0042632) | 9,76 | 3,21E-06 | protein autophosphorylation (GO:0046777) | 3,05 | 4,19E-05 |